Isointense model for the evaluation of tumor-specific MRI contrast agents
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 6 (3) , 275-280
- https://doi.org/10.1016/0730-725x(88)90402-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumorsAmerican Journal of Roentgenology, 1987
- Tissue distribution and stability of metalloporphyrin MRI contrast agentsMagnetic Resonance in Medicine, 1987
- Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor systemMagnetic Resonance Imaging, 1987
- Optimal pulse sequence for imaging hepatic metastases.Radiology, 1986
- Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.Radiology, 1986
- Initial clinical evaluation of gadolinium DTPA for contrast-enhanced magnetic resonance imagingMagnetic Resonance Imaging, 1985
- Pulse sequence optimization for MR imaging using a paramagnetic hepatobiliary contrast agent.Radiology, 1985
- MR Imaging of Central Nervous System Tumors that Do Not Display Increase in Tl or T2Journal of Computer Assisted Tomography, 1985
- Optimizing tissue contrast in magnetic resonance imagingMagnetic Resonance Imaging, 1984
- A signal-to-noise calibration procedure for NMR imaging systemsMedical Physics, 1984